Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Instituts de recherche en santé du Canada
12 584 captures · dernière capture : 10 avr. 2025
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Notice of Intent: Transitioning Product Monographs to a Structured Format April 10, 2019 Our file number: 19-107892-703 Health Canada is pleased to announce its intent to transition product monograph templates to a new structured format based on Extensible Markup Language (XML),…
Questions and Answers: Plain Language Labelling Regulations for Prescription Drugs - document Date adopted: 2015/04/30 Date posted: 2020/03/23 Effective date: 2020/04/01 PDF version Document change log Version Guidance Document: Questions and Answers: Plain Language Labelling…
Notice - Final Release: Part I - Health Professional Information and Part II - Scientific Information of the Guidance Document - Product Monograph December 9, 2016 Reference number: 16-113259-317 This notice was updated on May 12, 2020. Under the continuing efforts of the Health…
Notice: Product Monograph Implementation Plans May 12, 2020 Our Reference No: 19-123473-315 UPDATE: In light of current priorities and circumstances related to COVID-19, Health Canada is revising the Product Monograph Implementation timelines. Health Canada will initiate Phase I:…
Product monograph guidance documents and notices Contact: Bureau of Policy, Science and International Programs On this page Product monograph guidance Notices Archived notices Product monograph guidance Guidance Document: Product Monograph [2024-12-23] Product Monograph Master…
Border requirements for importing and exporting health products (COVID-19) There is an unprecedented demand and urgent need for access to health products during the COVID-19 pandemic. As part of Canada's response to COVID-19, interim measures and interim orders (IO) are in place…
Health Canada’s regulatory response to COVID-19: International engagement Access to health products International engagement During the COVID-19 pandemic, Health Canada is working closely with domestic and international partners to anticipate and meet Canadians' health product…
Drug and vaccine authorizations for COVID-19: Overview Overview List of applications received List of authorized drugs On this page About market authorization Prioritizing COVID-19 applications and being transparent Authorization pathways for COVID-19 drugs and vaccines…
Conducting a COVID-19 drug and vaccine clinical trial Conducting a COVID-19 clinical trial List of authorized clinical trials On this page Clinical trial regulations Applying to conduct a clinical trial for COVID-19 purposes Clinical trial regulations Clinical trials are studies…
Drugs and vaccines for COVID-19 On this page Regulatory response to COVID-19 Regulating drugs and vaccines sold in Canada Monitoring SARS-CoV-2 variants Potential drugs and vaccines for COVID-19 Clinical trials for drugs and vaccines Market authorization Special Access Program…
Page 2334 sur 3977Affichage de 23331 à 23340 sur 39762
Version préliminaire : la couverture et les fonctionnalités sont encore en expansion.
